South Africa Cancer Diagnostics Market Size & Outlook
South Africa cancer diagnostics market, 2018-2030 (US$M)
Related Markets
South Africa cancer diagnostics market highlights
- The South Africa cancer diagnostics market generated a revenue of USD 696.1 million in 2023 and is expected to reach USD 1,057.8 million by 2030.
- The South Africa market is expected to grow at a CAGR of 6.2% from 2024 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2023.
- Consumables is the most lucrative product segment registering the fastest growth during the forecast period.
Cancer diagnostics market data book summary
| Market revenue in 2023 | USD 696.1 million |
| Market revenue in 2030 | USD 1,057.8 million |
| Growth rate | 6.2% (CAGR from 2023 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Services, Instruments, Consumables |
| Key market players worldwide | Abbott Laboratories, Roche Holding AG, GE HealthCare Technologies Inc Common Stock, Qiagen NV, Becton Dickinson & Co, Koninklijke Philips NV, Siemens Healthineers AG ADR, Hologic Inc, Thermo Fisher Scientific Inc, Illumina Inc |
Other key industry trends
- In terms of revenue, South Africa accounted for 0.6% of the global cancer diagnostics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia cancer diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 609.1 million by 2030.
Consumables was the largest segment with a revenue share of 60.03% in 2023. Horizon Databook has segmented the South Africa cancer diagnostics market based on services, instruments, consumables covering the revenue growth of each sub-segment from 2018 to 2030.
The South Africa cancer diagnostics market is competitive owing to the local presence of multiple global players and domestic manufacturers. Some of the leading liquid biopsy providers in the country are PathCare, Axaitech, QIAGEN, and Guardant Health.
The increasing prevalence & incidence of cancer and rising preference for noninvasive treatment procedures are among the leading factors driving the country’s market. Moreover, the increasing demand for noninvasive diagnostic procedures owing to the numerous advantages offered by them is another factor propelling market growth.
In addition, the presence of a large number of profit and nonprofit organizations that promote awareness about cancer screening and diagnosis is expected to support market expansion. For instance, The Cancer Association of South Africa encourages women and men to undergo routine health checkups & cancer screening.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cancer Diagnostics Market Scope
Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Africa cancer diagnostics market size, by product, 2018-2030 (US$M)
South Africa Cancer Diagnostics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
